More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

Wegovy is a GLP-1 agonist containing semaglutide ... GLP-1 agonists may improve blood pressure and cholesterol, likely due to weight loss. Studies show weight loss can help lower total cholesterol.

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

However, studies have shown these risks in high ... strokes and a BMI of 27 kg/m² or higher. Learn more about Wegovy for weight loss. Ozempic, also semaglutide, is in the glucagon-like peptide ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity ...

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Helping kids with obesity drop pounds can have a huge impact on their future health.When these children and teens los ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...